Compare AUTL & RR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | RR |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.4M | 375.9M |
| IPO Year | 2025 | 2023 |
| Metric | AUTL | RR |
|---|---|---|
| Price | $1.18 | $0.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.36 | N/A |
| AVG Volume (30 Days) | 2.5M | ★ 5.3M |
| Earning Date | 11-10-2026 | 08-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | $5,045,000.00 |
| Revenue This Year | $101.75 | $8.03 |
| Revenue Next Year | $29.27 | $22.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 496.00 | 18.99 |
| 52 Week Low | $1.12 | $0.80 |
| 52 Week High | $2.58 | $5.60 |
| Indicator | AUTL | RR |
|---|---|---|
| Relative Strength Index (RSI) | 24.83 | 27.23 |
| Support Level | N/A | N/A |
| Resistance Level | $1.71 | $1.79 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 9.43 | 4.17 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).